Berberine: A Promising Treatment for Neurodegenerative Diseases

被引:41
|
作者
Cheng, Ziqian [1 ]
Kang, Chenglan
Che, Songtian
Su, Jingyun [1 ]
Sun, Qihan
Ge, Tongtong
Guo, Yi [1 ]
Lv, Jiayin
Sun, Zhihui [2 ]
Yang, Wei [1 ]
Li, Bingjin
Li, Xin [1 ]
Cui, Ranji [1 ]
机构
[1] Second Hosp Jilin Univ, Jilin Prov Key Lab Mol & Chem Genet, Changchun, Peoples R China
[2] First Hosp Jilin Univ, Dept Pharm, Changchun, Peoples R China
基金
中国国家自然科学基金;
关键词
berberine; neurodegenerative diseases; neuroinflammation; neuroprotection; oxidative stress; MAO-B INHIBITOR; OXIDATIVE STRESS; MUTANT-HUNTINGTIN; TAU HYPERPHOSPHORYLATION; COGNITIVE IMPAIRMENT; MULTIPLE-SCLEROSIS; CEREBRAL-ISCHEMIA; RESEARCH PROGRESS; PC12; CELLS; RAT MODEL;
D O I
10.3389/fphar.2022.845591
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Berberine, as a natural alkaloid compound, is characterized by a diversity of pharmacological effects. In recent years, many researches focused on the role of berberine in central nervous system diseases. Among them, the effect of berberine on neurodegenerative diseases has received widespread attention, for example Alzheimer's disease, Parkinson's disease, Huntington's disease, and so on. Recent evidence suggests that berberine inhibits the production of neuroinflammation, oxidative, and endoplasmic reticulum stress. These effects can further reduce neuron damage and apoptosis. Although the current research has made some progress, its specific mechanism still needs to be further explored. This review provides an overview of berberine in neurodegenerative diseases and its related mechanisms, and also provides new ideas for future research on berberine.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Berberine: Is it a Promising Agent for Mental Disorders Treatment?
    Shayganfard, Mehran
    CURRENT MOLECULAR PHARMACOLOGY, 2023, 16 (03) : 307 - 320
  • [22] Ferroptosis in neurodegenerative diseases: inhibitors as promising candidate mitigators
    Zhang, R-F
    Zeng, M.
    Lv, N.
    Wang, L-M
    Yang, Q-Y
    Gan, J-L
    Li, H-H
    Yu, B.
    Jiang, X-J
    Yang, L.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (01) : 46 - 65
  • [23] Retinoids and PPAR agonists: Promising partners in neurodegenerative diseases?
    Riancho, Javier
    FREE RADICAL BIOLOGY AND MEDICINE, 2016, 97 : 616 - 617
  • [24] Promising Results in the Therapeutic Use of Antioxidants in Neurodegenerative Diseases
    Bilbis, Lawal S.
    Saidu, Y.
    Abbas, A. Y.
    Balarabe, S.
    Ibrahim, B.
    Suleiman, N.
    Wali, U.
    Jinjiri, N.
    BIOCHEMISTRY AND CELL BIOLOGY, 2023, 101 (06)
  • [25] Olesoxime in neurodegenerative diseases: Scrutinising a promising drug candidate
    Weber, Jonasz Jeremiasz
    Clemensson, Laura Emily
    Schioth, Helgi Birgir
    Huu Phuc Nguyen
    BIOCHEMICAL PHARMACOLOGY, 2019, 168 : 305 - 318
  • [26] Tetramethoxyluteolin for the Treatment of Neurodegenerative Diseases
    Theoharides, Theoharis C.
    Tsilioni, Irene
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2018, 18 (21) : 1872 - 1882
  • [27] Pharmacological treatment of neurodegenerative diseases
    Iwona Kurkowska-Jastrzębska
    Pharmacological Reports, 2010, 62 : 25 - 26
  • [28] Pharmacological treatment of neurodegenerative diseases
    Kurkowska-Jastrzebska, Iwona
    PHARMACOLOGICAL REPORTS, 2010, 62 : 25 - 26
  • [29] Combating Neurodegenerative Diseases with the Plant Alkaloid Berberine: Molecular Mechanisms and Therapeutic Potential
    Fan, Dahua
    Liu, Liping
    Wu, Zhengzhi
    Cao, Meiqun
    CURRENT NEUROPHARMACOLOGY, 2019, 17 (06) : 563 - 579
  • [30] Targeting protein aggregation: the promising application of polyoxometalates in neurodegenerative diseases
    Chen, Junyi
    Yang, Wen-Zhu
    Chen, Huilan
    Ding, Xiuxia
    Chen, Hongxu
    Zhan, Cai-Hong
    Jin, Zhigang
    INORGANIC CHEMISTRY FRONTIERS, 2024, 11 (21): : 7238 - 7255